|
1.
|
Washington, DC -- For the estimated 83,000 women who will be diagnosed with a gynecologic cancer in 2010, participation in clinical trials offers an opportunity both to ensure that future patients be...
|
September 2010
|
|
2.
|
Washington, DC -- Girls ages 11 to 12 should receive either of the two FDA-approved vaccines to prevent cervical cancer, ideally before they become sexually active, according to The American College ...
|
August 2010
|
|
3.
|
San Francisco, CA -- Young women undergoing cancer treatment have an increasing number of options for preserving their fertility, a leading researcher told attendees today at the 58th Annual Clinical...
|
May 2010
|
|
4.
|
Washington, DC -- The birth control pill, the most studied medication in the world, reaches its 50-year milestone this month. Since the introduction of the pill in the US, numerous types of hormonal ...
|
May 2010
|
|
5.
|
Washington, DC -- Hormonal contraceptives are effective in treating menstruation- related disorders such as dysmenorrhea and heavy menstrual bleeding, as well as preventing unplanned pregnancies, acc...
|
December 2009
|
|
6.
|
Number 412
(Reaffirmed 2012)
ABSTRACT: Aromatase inhibitors appear to be effective as an adjuvant treatment for early-stage and late-stage breast cancer. Their role in chemoprevention of breast cancer in high-risk patients remai...
|
August 2008
PDF Download
|
|
7.
|
Number 396
(Reaffirmed 2010 )
ABSTRACT: Postoperative intravenous (IV) chemotherapy for advanced stage ovarian cancer has been the standard treatment. Recent studies have found significant survival advantages with the use of adju...
|
January 2008
PDF Download
|
|
8.
|
Washington, DC -- Blood clots are a leading cause of disability and death in patients following surgery, despite medical advances in their prevention, diagnosis, and treatment. The American College o...
|
July 2007
|
|
9.
|
Number 336
(Reaffirmed 2008, Replaces No. 232, April 2000)
ABSTRACT: Tamoxifen may be associated with endometrial proliferation, hyperplasia, polyp formation, invasive carcinoma, and uterine sarcoma. Any symptoms of endometrial hyperplasia or cancer reported...
|
June 2006
PDF Download
|